# Filing Detail

Form 8-K - Current report:
SEC Accession No. 0001193125-22-238873
Filing Date
2022-09-06
Accepted
2022-09-06 16:21:14
Documents
42
Period of Report
2022-09-06
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | FORM 8-K | d393616d8k.htm iXBRL | 8-K | 26297
2 | EX-99.1 | d393616dex991.htm | EX-99.1 | 30508
6 | GRAPHIC | g393616g04a01.jpg | GRAPHIC | 203812
7 | GRAPHIC | g393616g05a01.jpg | GRAPHIC | 406560
8 | GRAPHIC | g393616g06a01.jpg | GRAPHIC | 265653
9 | GRAPHIC | g393616g07a01.jpg | GRAPHIC | 188164
10 | GRAPHIC | g393616g08a01.jpg | GRAPHIC | 160245
11 | GRAPHIC | g393616g09a01.jpg | GRAPHIC | 291540
12 | GRAPHIC | g393616g10a01.jpg | GRAPHIC | 222700
13 | GRAPHIC | g393616g11a01.jpg | GRAPHIC | 193778
14 | GRAPHIC | g393616g12a01.jpg | GRAPHIC | 230064
15 | GRAPHIC | g393616g13a01.jpg | GRAPHIC | 187622
16 | GRAPHIC | g393616g14a01.jpg | GRAPHIC | 165128
17 | GRAPHIC | g393616g15a01.jpg | GRAPHIC | 121064
18 | GRAPHIC | g393616g16a01.jpg | GRAPHIC | 139360
19 | GRAPHIC | g393616g17a01.jpg | GRAPHIC | 264314
20 | GRAPHIC | g393616g18a01.jpg | GRAPHIC | 142963
21 | GRAPHIC | g393616g19a01.jpg | GRAPHIC | 209831
22 | GRAPHIC | g393616g20a01.jpg | GRAPHIC | 132424
23 | GRAPHIC | g393616g21a01.jpg | GRAPHIC | 251358
24 | GRAPHIC | g393616g22a01.jpg | GRAPHIC | 167765
25 | GRAPHIC | g393616g23a01.jpg | GRAPHIC | 223976
26 | GRAPHIC | g393616g24a01.jpg | GRAPHIC | 151293
27 | GRAPHIC | g393616g25a01.jpg | GRAPHIC | 268466
28 | GRAPHIC | g393616g26a01.jpg | GRAPHIC | 282718
29 | GRAPHIC | g393616g27a01.jpg | GRAPHIC | 251943
30 | GRAPHIC | g393616g28a01.jpg | GRAPHIC | 260287
31 | GRAPHIC | g393616g29a01.jpg | GRAPHIC | 179241
32 | GRAPHIC | g393616g30a01.jpg | GRAPHIC | 154706
33 | GRAPHIC | g393616g31a01.jpg | GRAPHIC | 247890
34 | GRAPHIC | g393616g32a01.jpg | GRAPHIC | 133189
| Complete submission text file | 0001193125-22-238873.txt |  | 8587588

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
3 | XBRL TAXONOMY EXTENSION SCHEMA | rapt-20220906.xsd | EX-101.SCH | 2847
4 | XBRL TAXONOMY EXTENSION LABEL LINKBASE | rapt-20220906_lab.xml | EX-101.LAB | 17978
5 | XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE | rapt-20220906_pre.xml | EX-101.PRE | 11252
36 | EXTRACTED XBRL INSTANCE DOCUMENT | d393616d8k_htm.xml | XML | 3355

Mailing Address 561 ECCLES AVENUE SOUTH SAN FRANCISCO CA 94080
Business Address 561 ECCLES AVENUE SOUTH SAN FRANCISCO CA 94080 (650) 489-9000
RAPT Therapeutics, Inc. (Filer) CIK: 0001673772 (see all company filings)

EIN.: 473313701 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38997 | Film No.: 221228512
SIC: 2834 Pharmaceutical Preparations